TransUnion Receives Analyst Ratings, Reports Exceeding-Estimates EPS

Summary

TransUnion (NYSE: TRU) has received a ‘moderate buy’ rating from analysts, with 10 buy, 4 hold, and 1 sell recommendations. The average 1-year price target is $112.46. Recent target price changes include UBS raising its target to $105 and BMO Capital Markets increasing it to $118. The stock opened at $90.98, with a market cap of $17.72 billion and a PE ratio of 45.49. TransUnion reported $1.08 EPS for the last quarter, exceeding estimates, and revenue increased by 9.5% year-over-year. Insider trading activity has been noted, with several shares sold recently.Market Beat

Impact Analysis

TransUnion’s strong earnings report and favorable analyst ratings indicate a positive outlook for the company at the company level. The stock’s EPS exceeded market expectations, suggesting robust financial health, which can lead to increased investor confidence and potentially higher stock prices. Analyst price target increases from UBS and BMO Capital Markets to $105 and $118, respectively, reflect confidence in future performance. However, recent insider sales could indicate potential caution or profit-taking by insiders. The stock’s recent price fluctuations, with a maximum rise of 9.64% and a maximum fall of 8.39% over the last 18 trading days, highlight volatility and may present buying opportunities for investors looking to capitalize on short-term movements. Overall, the combination of positive earnings, analyst ratings, and price targets suggests potential investment opportunities in TransUnion, although investors should be mindful of insider trading activity and volatility.Reuters+ 2